High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 469.78 Thousand USD | 8.38% |
| 2021 | 433.45 Thousand USD | 6.49% |
| 2020 | 407.03 Thousand USD | 7.3% |
| 2019 | 379.35 Thousand USD | 272.23% |
| 2018 | -220.25 Thousand USD | -225.74% |
| 2017 | 175.16 Thousand USD | -30.17% |
| 2016 | 250.85 Thousand USD | 66.04% |
| 2015 | 151.08 Thousand USD | -7.54% |
| 2014 | 163.39 Thousand USD | 18.62% |
| 2013 | 137.74 Thousand USD | 1252090.91% |
| 2012 | 11.00 USD | -80.36% |
| 2011 | 56.00 USD | -99.93% |
| 2010 | 79.97 Thousand USD | 34.02% |
| 2009 | 59.67 Thousand USD | -0.54% |
| 2008 | 59.99 Thousand USD | 20.19% |
| 2007 | 49.91 Thousand USD | 29290.64% |
| 2006 | -171.00 USD | -755.0% |
| 2005 | -20.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 509.49 Thousand USD | 8.45% |
| 2023 Q3 | 606.98 Thousand USD | 16.59% |
| 2023 Q2 | 520.59 Thousand USD | 2.18% |
| 2022 FY | 469.78 Thousand USD | 8.38% |
| 2022 Q3 | 586.49 Thousand USD | 2.23% |
| 2022 Q2 | 573.67 Thousand USD | 15.82% |
| 2022 Q1 | 495.31 Thousand USD | 14.27% |
| 2022 Q4 | 469.78 Thousand USD | -19.9% |
| 2021 Q2 | 422 Thousand USD | -4.51% |
| 2021 Q3 | 442 Thousand USD | 4.74% |
| 2021 Q4 | 433.45 Thousand USD | -1.93% |
| 2021 FY | 433.45 Thousand USD | 6.49% |
| 2021 Q1 | 441.91 Thousand USD | 8.57% |
| 2020 Q3 | 371.46 Thousand USD | -5.33% |
| 2020 FY | 407.03 Thousand USD | 7.3% |
| 2020 Q1 | 386.88 Thousand USD | 1.99% |
| 2020 Q2 | 392.36 Thousand USD | 1.42% |
| 2020 Q4 | 407.03 Thousand USD | 9.58% |
| 2019 Q4 | 379.35 Thousand USD | 12.65% |
| 2019 Q2 | 41.56 Thousand USD | 125.09% |
| 2019 Q1 | -165.7 Thousand USD | 24.77% |
| 2019 Q3 | 336.76 Thousand USD | 710.14% |
| 2019 FY | 379.35 Thousand USD | 272.23% |
| 2018 Q1 | 291.81 Thousand USD | 2.26% |
| 2018 Q4 | -220.25 Thousand USD | -174.2% |
| 2018 FY | -220.25 Thousand USD | -225.74% |
| 2018 Q2 | 316.45 Thousand USD | 8.45% |
| 2018 Q3 | 296.85 Thousand USD | -6.19% |
| 2017 Q3 | 279.04 Thousand USD | 2.41% |
| 2017 FY | 175.16 Thousand USD | -30.17% |
| 2017 Q1 | 266.09 Thousand USD | -7.32% |
| 2017 Q4 | 285.34 Thousand USD | 2.26% |
| 2017 Q2 | 272.48 Thousand USD | 2.4% |
| 2016 Q3 | 243.04 Thousand USD | 4.21% |
| 2016 Q4 | 287.12 Thousand USD | 18.14% |
| 2016 FY | 250.85 Thousand USD | 66.04% |
| 2016 Q2 | 233.21 Thousand USD | 3.21% |
| 2016 Q1 | 225.96 Thousand USD | 4.26% |
| 2015 Q4 | 216.73 Thousand USD | 3.74% |
| 2015 Q1 | 183.29 Thousand USD | 12.18% |
| 2015 FY | 151.08 Thousand USD | -7.54% |
| 2015 Q2 | 193.62 Thousand USD | 5.64% |
| 2015 Q3 | 208.91 Thousand USD | 7.9% |
| 2014 Q3 | 155.68 Thousand USD | 4.82% |
| 2014 Q4 | 163.39 Thousand USD | 4.95% |
| 2014 Q1 | 145.46 Thousand USD | 5.61% |
| 2014 Q2 | 148.52 Thousand USD | 2.1% |
| 2014 FY | 163.39 Thousand USD | 18.62% |
| 2013 Q1 | 682.00 USD | 6100.0% |
| 2013 FY | 137.74 Thousand USD | 1252090.91% |
| 2013 Q4 | 137.74 Thousand USD | 1.76% |
| 2013 Q3 | 135.35 Thousand USD | 8.58% |
| 2013 Q2 | 124.66 Thousand USD | 18179.18% |
| 2012 Q4 | 11.00 USD | -99.99% |
| 2012 Q3 | 109.81 Thousand USD | 10.14% |
| 2012 Q2 | 99.7 Thousand USD | 2033.27% |
| 2012 FY | 11.00 USD | -80.36% |
| 2012 Q1 | 4674.00 USD | 8246.43% |
| 2011 FY | 56.00 USD | -99.93% |
| 2011 Q4 | 56.00 USD | -99.94% |
| 2011 Q3 | 89.59 Thousand USD | 12.38% |
| 2011 Q2 | 79.72 Thousand USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2010 Q1 | 70 Thousand USD | 16.67% |
| 2010 Q4 | 79.97 Thousand USD | 14.34% |
| 2010 Q3 | 69.94 Thousand USD | 0.04% |
| 2010 FY | 79.97 Thousand USD | 34.02% |
| 2010 Q2 | 69.91 Thousand USD | -0.12% |
| 2009 Q3 | 59.95 Thousand USD | 0.04% |
| 2009 FY | 59.67 Thousand USD | -0.54% |
| 2009 Q4 | 60 Thousand USD | 0.07% |
| 2009 Q1 | 59.9 Thousand USD | 6.52% |
| 2009 Q2 | 59.93 Thousand USD | 0.04% |
| 2008 Q4 | 56.24 Thousand USD | 57488.78% |
| 2008 Q2 | -3145.00 USD | -227.48% |
| 2008 Q1 | 2467.00 USD | 3036.9% |
| 2008 FY | 59.99 Thousand USD | 20.19% |
| 2008 Q3 | -98.00 USD | 96.88% |
| 2007 Q2 | -776.00 USD | -431.51% |
| 2007 Q4 | -84.00 USD | 88.86% |
| 2007 FY | 49.91 Thousand USD | 29290.64% |
| 2007 Q1 | -146.00 USD | 14.62% |
| 2007 Q3 | -754.00 USD | 2.84% |
| 2006 Q3 | -195.00 USD | -6400.0% |
| 2006 Q4 | -171.00 USD | 12.31% |
| 2006 FY | -171.00 USD | -755.0% |
| 2006 Q2 | -3.00 USD | 0.0% |
| 2005 FY | -20.00 USD | 0.0% |
| 2005 Q4 | -20.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioQuest Corp. | 177.38 Thousand USD | -164.839% |
| GSRX Industries Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |